Ambit Health Ventures
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Ambit Health Ventures.
Key people at Ambit Health Ventures.
Ambit Health Ventures is a boutique early-stage venture capital firm specializing in healthcare innovation, with a focus on digital health, Medtech, healthcare services, and biotechnology. Its mission is to improve healthcare outcomes by investing in visionary startups that develop cutting-edge digital diagnostics, digital therapeutics, and tech-enabled healthcare services. The firm supports these startups with capital, strategic guidance, and operational expertise to accelerate growth while delivering strong financial returns to its investors. Ambit Health Ventures plays a significant role in advancing healthcare innovation by backing technologies that address unmet medical needs, such as Smartlens, Inc., which develops microfluidics-based soft contact lenses for glaucoma monitoring[1][2][3].
Founded in 2021 and headquartered in Massachusetts, Ambit Health Ventures was co-founded by Naomi Fried and Sam Goldberger, who bring deep experience in healthcare and venture capital. The firm evolved with a clear focus on early-stage investments in essential digital health and Medtech innovations, aiming to bridge the gap between breakthrough healthcare technologies and market adoption. Its leadership team, including managing partners with a strong track record in venture capital, emphasizes hands-on operational support and strategic partnerships to help portfolio companies scale effectively[2][3].
Ambit Health Ventures is positioned at the intersection of healthcare and technology, riding the wave of digital transformation in medicine. The firm capitalizes on trends such as personalized medicine, remote patient monitoring, and AI-driven diagnostics, which are reshaping healthcare delivery. The timing is critical as healthcare systems increasingly adopt digital solutions to improve patient outcomes and reduce costs. By funding early-stage innovators, Ambit Health Ventures influences the broader ecosystem by accelerating the commercialization of disruptive health technologies that can transform clinical practice and patient care[1][2].
Looking ahead, Ambit Health Ventures is likely to continue expanding its portfolio in digital health and Medtech, focusing on scalable solutions that address pressing healthcare challenges. Trends such as telemedicine, wearable health devices, and AI-powered diagnostics will shape its investment strategy. The firm’s influence is expected to grow as it helps startups navigate regulatory pathways and market complexities, ultimately contributing to a more innovative and efficient healthcare system. Its commitment to early-stage ventures positions it well to identify and nurture the next generation of healthcare breakthroughs[1][2][3].
Key people at Ambit Health Ventures.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2025 | Smartlens | $5.0M Venture Round | — | Blackwood Healthcare Breakthroughs, Connecticut Innovations |
| May 1, 2024 | Encapsulate | $2.0M Seed | — | Blackwood Healthcare Breakthroughs, Connecticut Innovations |
| Jul 1, 2023 | Smartlens | $6.0M Series A | — | Blackwood Healthcare Breakthroughs, Connecticut Innovations |
| Sep 1, 2022 | SOAP Health | $2.0M Seed | — | — |
| Dec 1, 2021 | AEENA Dx | $48K Series A | — | Esplanade HealthTech Ventures, Good Growth Capital |
| Dec 1, 2020 | Bone Health Technologies | $2.0M Series A | — | Good Growth Capital |
